MLYS Smart Money
Mineralys Therapeutics, Inc.
1W: -8.6%
1M: -18.6%
3M: -18.9%
YTD: -33.8%
1Y: -40.6%
3Y: +139.9%
$23.63
-0.09 (-0.38%)
Weekly Expected Move ±9.1%
$19
$21
$24
$26
$28
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q2 2026251
Institutions Holding
-2 vs prior
126.8%
Ownership
+10.95%
38
New
91
Increased
87
Reduced
22
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | Congleton Jon | officer: chief executive officer | S-Sale | 75,000 | $25.46 | $1.9M | Filing |
| 2026-09-22 | Slingsby Brian Taylor | director | S-Sale | 104,320 | $28.81 | $3.0M | Filing |
| 2026-09-21 | Warren Eric | officer: chief commercial officer | S-Sale | 7,438 | $28.12 | $209K | Filing |
| 2026-09-15 | Karydas Daphne | director | S-Sale | 3,000 | $28.58 | $86K | Filing |
| 2026-08-21 | Warren Eric | officer: chief commercial officer | S-Sale | 7,437 | $25.98 | $193K | Filing |
| 2026-08-10 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,170 | $27.09 | $59K | Filing |
| 2026-08-10 | Ferguson James J. III | officer: chief medical officer | A-Grant/Award | 102,400 | $— | $0 | Filing |
| 2026-07-21 | Warren Eric | officer: chief commercial officer | S-Sale | 7,438 | $26.87 | $200K | Filing |
| 2026-07-17 | Rodman David Malcom | officer: chief medical officer | S-Sale | 416 | $26.53 | $11K | Filing |
| 2026-07-15 | Rodman David Malcom | officer: chief medical officer | S-Sale | 6,349 | $26.61 | $169K | Filing |
| 2026-07-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 14,058 | $27.58 | $388K | Filing |
| 2026-07-13 | Congleton Jon | officer: chief executive officer | S-Sale | 10,700 | $27.24 | $291K | Filing |
| 2026-07-09 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,171 | $30.30 | $66K | Filing |
| 2026-06-30 | Congleton Jon | officer: chief executive officer | S-Sale | 17,000 | $26.82 | $456K | Filing |
| 2026-06-30 | Congleton Jon | officer: chief executive officer | S-Sale | 58,000 | $25.94 | $1.5M | Filing |
| 2026-06-26 | Warren Eric | officer: chief commercial officer | S-Sale | 104,124 | $25.90 | $2.7M | Filing |
| 2026-06-17 | Karydas Daphne | director | S-Sale | 3,000 | $25.00 | $75K | Filing |
| 2026-06-17 | Rodman David Malcom | officer: chief medical officer | S-Sale | 4,584 | $25.00 | $115K | Filing |
| 2026-06-15 | Rodman David Malcom | officer: chief medical officer | S-Sale | 9,890 | $23.81 | $235K | Filing |
| 2026-06-12 | Rodman David Malcom | officer: chief medical officer | S-Sale | 6,349 | $23.93 | $152K | Filing |
| 2026-06-10 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,170 | $25.00 | $54K | Filing |
| 2026-05-18 | Rodman David Malcom | officer: chief medical officer | S-Sale | 417 | $27.55 | $11K | Filing |
| 2026-05-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 14,056 | $28.58 | $402K | Filing |
| 2026-05-12 | Rodman David Malcom | officer: chief medical officer | S-Sale | 6,348 | $29.36 | $186K | Filing |
| 2026-05-11 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,171 | $29.71 | $65K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Catalys Pacific, LLC | 7,903,838 | $213M | — | 2026-06-30 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 7,692,750 | $208M | — | 2026-06-30 | Filing |
| BlackRock, Inc. | 5,887,038 | $159M | +1,405,456 | 2026-06-30 | Filing |
| SAMSARA BIOCAPITAL, LLC | 5,871,018 | $158M | — | 2026-06-30 | Filing |
| FMR LLC | 4,511,689 | $122M | -349,415 | 2026-06-30 | Filing |
| STATE STREET CORP | 4,141,636 | $112M | +1,205,696 | 2026-06-30 | Filing |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,958,000 | $107M | +3,958,000 | 2026-06-30 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,756,770 | $74M | +302,407 | 2026-06-30 | Filing |
| Laurion Capital Management LP | 2,506,152 | $68M | +274,112 | 2026-06-30 | Filing |
| ORBIMED ADVISORS LLC | 2,110,300 | $57M | +57,400 | 2026-06-30 | Filing |
| Capital World Investors | 1,997,607 | $54M | +1,599,428 | 2026-06-30 | Filing |
| ARMISTICE CAPITAL, LLC | 1,736,000 | $47M | +560,000 | 2026-06-30 | Filing |
| Troluce Capital Advisors LLC | 1,728,753 | $47M | +1,073,753 | 2026-06-30 | Filing |
| FRANKLIN RESOURCES INC | 1,635,520 | $44M | -149,142 | 2026-06-30 | Filing |
| ANDERA PARTNERS | 1,591,917 | $43M | — | 2026-06-30 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,584,326 | $43M | +283,191 | 2026-06-30 | Filing |
| SR One Capital Management, LP | 1,563,966 | $42M | — | 2026-06-30 | Filing |
| BANK OF AMERICA CORP /DE | 1,505,547 | $41M | +405,175 | 2026-06-30 | Filing |
| SPHERA FUNDS MANAGEMENT LTD. | 1,469,971 | $40M | +130,000 | 2026-06-30 | Filing |
| GOLDMAN SACHS GROUP INC | 1,458,676 | $39M | +673,633 | 2026-06-30 | Filing |